We use technology to improve diagnostic and treatment accuracy for patients. We develop state of the art solutions to improve clinical outcome, and hence improve quality of life.
Biobot Surgical Pte Ltd aims to be a global technology leader in minimally-invasive robotic healthcare solutions.
Biobot Surgical Pte Ltd was incorporated in 2007 in Singapore, and became a member of ZIG Venture since 2011.
To ensure success, a team of talents has been put together in the areas of robotic design and technology, medical image processing, software development and clinical application.
To date, the iSR’obot Mona Lisa has obtained key regulatory approvals, including Europe (CE mark), U.S.A (US FDA), Australia (TGA) and Singapore (HSA) and is being used in some of the most prestigious hospitals around the world.
Striving to become the gold standard in diagnosis and prognosis of prostate cancer, the Mona Lisa’s development has been a process of evolution and is the latest in our state of the art new generation designs.
We are going to exhibit at UAA 2019, held at Kuala Lumpur Convention Center, Malaysia, on 7-10 August 2019.
Visit us at Booth no. 50!
First Robotic Transperineal Prostate Biopsy in Indonesia. Performed by the team from Urology Department at RSCM Hospital.
Thank you for visiting our booth at the American Urology Association (AUA) Annual Meeting 2019 at Chicago on 3-5 May 2019.
See you next year!
We will be exhibiting at Booth no. 14!
Come and check out the live demonstration of Mona Lisa, the robotic prostate biopsy system, at Brisbane Convention & Exhibition Centre on 14 – 16 April 2019.
For more info on the event, please visit: https://www.usanz2019.com/
We are excited to be participating in the upcoming 34th Annual European Association of Urology (EAU) Congress. It is going to be held in Barcelona, Spain from 15 till 19 March 2019. To all those who are also attending this congress, please visit us at booth no. F54!